INmune Bio, Inc. (INMB) Ownership
INMB ownership summary
as of October 18, 2026- Institutions
- 15.6% of shares outstanding
- Insiders
- 10.75% of shares outstanding
- Shares outstanding
- 27.8M
- Float
- 23.3M shares available to trade
- Short interest
- 10.72% 2.7M shares short
- Days to cover
- 7.85 short interest up 18.1% vs prior month
- Institutions 15.59%
- Insiders 10.75%
- Other investors 73.66%
INMB top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 2.55% | 706K | $1.1M | +19,409 (+2.8%) | June 30, 2026 |
| 2 | AQR Capital Management LLC | 2.39% | 662K | $1.0M | +391,901 (+145.0%) | June 30, 2026 |
| 3 | BlackRock Inc | 1.12% | 312K | $489,232 | −882,499 (−73.9%) | June 30, 2026 |
| 4 | Geode Capital Management, LLC | 0.69% | 190K | $298,638 | −304,754 (−61.6%) | June 30, 2026 |
| 5 | The Goldman Sachs Group Inc | 0.67% | 185K | $290,835 | −46,341 (−20.0%) | June 30, 2026 |
| 6 | Millennium Management LLC | 0.57% | 160K | $250,508 | +159,559 (0.0%) | June 30, 2026 |
| 7 | Susquehanna International Group, LLP | 0.57% | 158K | $248,770 | −35,939 (−18.5%) | June 30, 2026 |
| 8 | Jane Street Group LLC | 0.48% | 134K | $210,744 | +83,288 (+163.5%) | June 30, 2026 |
| 9 | UBS Group AG | 0.40% | 110K | $173,348 | −142,927 (−56.4%) | June 30, 2026 |
| 10 | Westside Investment Management, Inc. | 0.39% | 108K | $170,031 | — | June 30, 2026 |
| 11 | Citadel Advisors Llc | 0.38% | 106K | $166,783 | +106,231 (0.0%) | June 30, 2026 |
| 12 | Vanguard Fiduciary Trust Co | 0.38% | 105K | $164,497 | −18,409 (−14.9%) | June 30, 2026 |
| 13 | State Street Corp | 0.34% | 93K | $146,580 | −197,516 (−67.9%) | June 30, 2026 |
| 14 | HRT FINANCIAL LLC | 0.30% | 84K | $132,442 | +84,358 (0.0%) | June 30, 2026 |
| 15 | IEQ CAPITAL, LLC | 0.30% | 82K | $129,344 | +57,822 (+235.4%) | June 30, 2026 |
| 16 | GSA Capital Partners LLP | 0.30% | 82K | $128,726 | +81,991 (0.0%) | June 30, 2026 |
| 17 | Virtu Financial LLC | 0.27% | 75K | $118,083 | +75,212 (0.0%) | June 30, 2026 |
| 18 | Laird Norton Tyee Trust Co | 0.19% | 52K | $81,640 | +2,000 (+4.0%) | June 30, 2026 |
| 19 | Buckingham Strategic Partners | 0.16% | 44K | $68,383 | +531 (+1.2%) | June 30, 2026 |
| 20 | PNC Financial Services Group Inc | 0.15% | 43K | $66,942 | +2,518 (+6.3%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 1.1M shares and 7 cut 1.6M.
INMB top mutual fund and ETF holders
12 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 1.77% | 490K | $769,721 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.61% | 170K | $267,368 | −19,255 (−10.2%) | August 31, 2026 |
| 3 | Abante Quant Value FI | 0.29% | 80K | $126,010 | — | July 31, 2026 |
| 4 | iShares Micro-Cap ETF | 0.28% | 78K | $122,195 | −537 (−0.7%) | September 30, 2026 |
| 5 | Fidelity Total Market Index | 0.11% | 29K | $45,850 | — | August 31, 2026 |
| 6 | Fidelity Series Total Market Index | 0.10% | 27K | $41,748 | — | August 31, 2026 |
| 7 | Vanguard Balanced Index Inv | 0.07% | 20K | $31,653 | — | August 31, 2026 |
| 8 | Fidelity Nasdaq Composite Index | 0.04% | 12K | $18,790 | — | August 31, 2026 |
| 9 | DFA US Micro Cap I | 0.02% | 5,789 | $9,089 | +5,789 (0.0%) | August 31, 2026 |
| 10 | 1290 VT Micro Cap K | 0.02% | 5,575 | $8,753 | — | August 31, 2026 |
| 11 | Dimensional US Small Cap ETF | 0.02% | 4,267 | $6,699 | — | September 30, 2026 |
| 12 | Dimensional Global Core Equity USD Acc | 0.01% | 3,005 | $4,718 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
INMB insider transactions
latest 6| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-30 | David J Moss | Buy | $5.29 | 10,000 | $52,900 |
| 2024-09-12 | David J Moss | Buy | $6.38 | 7,690 | $49,062 |
| 2024-09-12 | Raymond Joseph Tesi | Buy | $6.38 | 15,380 | $98,124 |
| 2024-06-25 | Scott Juda | Buy | $7.27 | 5,000 | $36,350 |
| 2023-11-10 | Scott Juda | Buy | $6.95 | 7,000 | $48,650 |
| 2023-07-12 | Timothy J Schroeder | Sell | $11.01 | 10,000 | $110,100 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
INMB shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns INMB
Institutional investors own 15.6% of INmune Bio's shares and insiders 10.75%. The largest holder is Vanguard Capital Management, LLC with 2.55% of the shares (706K), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 7 reduced their stake in the latest filings. Short interest is 10.72% of the float, or 7.85 days of average trading volume. The share count rose 431.6% since 2016.
Related: INMB analyst forecast, INMB key metrics. See the INMB stock overview for the latest quote and news.
INMB ownership FAQ
Who owns the most INmune Bio stock?
The largest shareholders of INmune Bio are Vanguard Capital Management, LLC (2.55%), AQR Capital Management LLC (2.39%), BlackRock Inc (1.12%), Geode Capital Management, LLC (0.69%), The Goldman Sachs Group Inc (0.67%).
What percentage of INmune Bio is owned by institutions?
Institutions hold 15.6% of INmune Bio's shares outstanding; insiders hold 10.75%.
Which funds own INmune Bio?
The largest fund holders of INmune Bio are Vanguard MStar Total Stk Mkt Idx Invest (1.77%), Fidelity Extended Market Index (0.61%), Abante Quant Value FI (0.29%), iShares Micro-Cap ETF (0.28%), Fidelity Total Market Index (0.11%).
What is INmune Bio's short interest?
2.7M shares of INmune Bio were sold short, 10.72% of the float; at the average daily volume it would take 7.85 days to cover.
Are insiders buying or selling INmune Bio?
Of the latest 6 reported insider transactions in INmune Bio (since July 12, 2023), 5 were purchases and 1 were sales.
How many shares of INmune Bio are outstanding?
INmune Bio has 27.8M shares outstanding, of which 23.3M are in the public float.